Factors Influencing ADME Properties of Drugs: Advances and Applications (Part I)

Author:

Zhang Shuang-Qing1,Chen Feng2

Affiliation:

1. National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, 29 Nanwei Rd, Xicheng District, Beijing 100050, China

2. Department of Pharmacy, Children’s Hospital of Nanjing Medical University, 72 Guangzhou Rd, Gulou District, Nanjing 210008, China

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Pharmacology

Reference11 articles.

1. Zhang S.Q.; Chen F.; Absorption, disposition and pharmacokinetic properties of novel therapeutic modalities. Curr Drug Metab 2020,21(12),912

2. Zhang S.Q.; Chen F.; Absorption, disposition and pharmacokinetic properties of novel therapeutic modalities (Part II). Curr Drug Metab 2021,22(1),3-4

3. Abdul-Aziz M.H.; Alffenaar J.C.; Bassetti M.; Bracht H.; Dimopoulos G.; Marriott D.; Neely M.N.; Paiva J.A.; Pea F.; Sjovall F.; Timsit J.F.; Udy A.A.; Wicha S.G.; Zeitlinger M.; De Waele J.J.; Roberts J.A.; Infection section of European society of intensive care medicine (ESICM); pharmacokinetic/pharmacodynamic and critically Ill patient study groups of European society of clinical microbiology and infectious diseases (ESCMID); infectious diseases group of international association of therapeutic drug monitoring and clinical toxicology (IATDMCT); infections in the ICU and sepsis working group of international society of antimicrobial chemotherapy (ISAC). Antimicrobial therapeutic drug monitoring in critically ill adult patients: A position paper. Intens Care Med 2020,46(6),1127-1153

4. Liu Y.; Ge X.H.; Guo H.L.; Chen F.; Zhang Y.; Xu J.; Ji X.; Miao H.J.; A systematic review of linezolid pharmacokinetics/pharmacodynamics in patients undergoing continuous renal replacement therapy: Does one size fit all? Curr Drug Metab 2023,24(1),70-77

5. Telles J.P.; Morales R.; Yamada C.H.; Marins T.A.; D’Amaro Juodinis V.; Sztajnbok J.; Silva M.; Bassetti B.R.; Albiero J.; Tuon F.F.; Optimization of antimicrobial stewardship programs using therapeutic drug monitoring and pharmacokinetics-pharmacodynamics protocols: A cost-benefit review. Ther Drug Monit 2023,45(2),200-208

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3